The9 doubles down: AI gaming profits fuel biotech pivot

On July 27, 2026, The9 announced a pivotal leadership transition as veteran CFO George Lai, who brings 18 years of company experience, stepped into the CEO role, succeeding founder Jun Zhu who remains Executive Chairman. This change signals a strategic refocus aimed at accelerating the growth of the AI-native platform the9bit, which has impressively attracted 8 million users and hosted over 110,000 games within its first year. Both Lai and Zhu framed this handover as a meaningful turning point designed to leverage early traction into a sustainable and monetizable business, while also advancing The9’s broader ambitions in digital assets and AI innovation.

By early 2026, The9 Limited had transformed its financial trajectory, posting a record $23 million net income in Q1 driven primarily by the receipt of 1.425 billion 9BIT tokens and the rapid adoption of its AI-powered gaming platform, the9bit, which surpassed 8 million registered users and 110,000 user-created games since its August 2025 launch. This milestone marked the company's strongest quarterly profit since its 2004 IPO, signaling a successful pivot to digital assets and AI-driven user engagement.

The9's cryptocurrency portfolio, including significant holdings of BTC and 9BIT tokens, was valued at approximately $110 million by mid-2026, underscoring the substantial financial impact of its digital asset strategy. This valuation grew further by the second quarter, reaching around $120 million with 1.9 billion 9BIT tokens and 347 BTC, highlighting the company's robust position in the crypto space as a key driver of its financial growth.

To ensure sustained profitability, The9's board implemented a long-term incentive plan granting senior management equity awards up to 12% of outstanding shares, contingent on surpassing the Q1 net income in each subsequent quarter of 2026. This strategic move reflects strong confidence in the company's growth trajectory, fueled by the9bit platform's expanding user base and commercial partnerships, which include 41 brand partners and a pipeline of 127 potential collaborators supporting a sustainable creator economy.

The9's financial momentum accelerated in Q2 2026, with net income soaring to $32 million—a 39% sequential increase—driven largely by the fair-value recognition of additional 9BIT tokens received under its cooperation agreement with the 9BIT Foundation. This brought the first half net income to a historic $55 million, cementing digital assets and AI-powered platform growth as the twin engines propelling The9's record-breaking profitability.

By mid-2026, The9's AI-powered digital asset ecosystem, the9bit, had firmly established itself across Southeast Asia, securing 41 brand partnerships with major retail chains in Indonesia, Malaysia, and Vietnam, and ambitiously planning 127 more to seamlessly blend digital entertainment with physical retail experiences. This strategic expansion not only enhanced user engagement—evidenced by an average of 120,000 daily active users and increased foot traffic—but also drove a notable 35% rise in the $9BIT token value since late May, signaling robust market confidence as the company prepared to extend its footprint into American and European markets.

The9bit platform's growth was further fueled by its vibrant creator community, which by late August 2026 had generated over 180,000 games using proprietary AI-assisted tools, underscoring strong user engagement and the platform’s scalability. Coupled with the established network of 41 brand partnerships and a pipeline of 127 prospective collaborators, The9 is strategically positioned to deepen the integration of offline consumer activities with its online ecosystem. Looking ahead, The9 plans to tailor its expansion into the Americas and Europe by carefully navigating local market dynamics, user preferences, and regulatory landscapes, aiming to replicate its Southeast Asian success on a global scale.

The9's strategic investment in Nanyang Biologics (NYB) marks a bold pivot from its gaming origins into the cutting-edge realm of AI-driven biotechnology. NYB's proprietary AI platform, Vecura™, harnesses a vast library of over one million natural compounds to uncover novel bioactive drug candidates that conventional methods often miss, showcasing the transformative potential of AI in drug discovery. This technological edge positions NYB—and by extension The9—to capitalize on the rapidly evolving biotech landscape.

Following shareholder approval at RFAI's extraordinary general meeting, NYB is advancing toward a Nasdaq listing, a milestone that will elevate its profile and access to capital markets. Upon completion, The9, through its subsidiary Gamenow.net, is set to hold a significant 15% to 16% stake in the combined Nasdaq-listed entity, underscoring its commitment to diversifying beyond gaming. This move not only broadens The9's investment portfolio but also signals its strategic ambition to embed itself in promising AI sectors with robust growth trajectories.